Skip to content

Clinical trials

Withdrawn Phase 1/2 Multiple Myeloma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Phase: Phase 1/2 Status: Withdrawn Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20141
20151
20161
20172
20181
20192
20222
20233
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)2
Alliance Foundation Trials, LLC.1
Alliance for Clinical Trials in Oncology1
Bayer1
City of Hope Medical Center1
H. Lee Moffitt Cancer Center and Research Institute1
Hackensack Meridian Health1
Karyopharm Therapeutics Inc1
Kathleen Dorritie1
LaNova Medicines Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma18
Recurrence5
Leukemia3
Lymphoma3
Burkitt Lymphoma2
Congenital Abnormalities2
Infections2
Leukemia, Lymphocytic, Chronic, B-Cell2
Leukemia, Myeloid, Accelerated Phase2
Leukemia, Myeloid, Acute2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.